Abstract
Although the beneficial effect of subcutaneous injections of botulinum toxin type A (BTX-A) is well known in both blepharospasm and hemifacial spasm, the position of the injection sites around the orbicularis oculi may influence the effectiveness and side effects. Here we report results of preseptal and pretarsal BTX-A injections in 53 patients (25 blepharospasm and 28 hemifacial spasm) in whom we used both injection techniques successively. Pretarsal injections were used in 102 out of 186 treatments in blepharospasm group and in 84 out of 202 treatments in hemifacial spasm group. Pretarsal BTX-A treatment produced significantly higher response rate and longer duration of maximum response in both patient groups. This technique was also associated with a lower frequency of major side effects such as ptosis. We concluded that injections of BTX-A into the pretarsal, rather than the preseptal portion of the orbicularis oculi is more effective for treatment of involuntary eyelid closure due to contractions of this muscle.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 15 January 2001, Received in revised form: 11 May 2001, Accepted: 17 May 2001
Rights and permissions
About this article
Cite this article
Çakmur, R., Ozturk, V., Uzunel, F. et al. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neurol 249, 64–68 (2002). https://doi.org/10.1007/PL00007849
Issue Date:
DOI: https://doi.org/10.1007/PL00007849